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CASE STUDY
Strawberry milk-like blood in a subject 
with diabetic lipemia: dramatic change 
to transparent color after insulin therapy
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Abstract 
Introduction:  It is known that chylomicronemia is caused by several pathologies and is classified as primary and 
secondary chylomicronemia. Since hypertriglycemia is associated with an increased risk of cardiovascular disease and 
severe pancreatitis, it is very important to make a proper diagnosis of the cause of hypertriglycemia.
Case description:  We herein present the case of a 40-year-old male who developed severe hypertriglycemia 
accompanied with acute exacerbation of type 2 diabetes mellitus. On admission, his blood glucose level was 306 mg/
dl and HbA1c was 12.5 %. Moreover, serum triglyceride level was elevated up to 5661 mg/dl. When blood was drawn, 
it presented strawberry milk-like color. After receiving insulin treatment, he obtained good glycemic control and the 
serum became back to normal transparent color.
Discussion and Evaluation: Insulin resistance reduces triglyceride clearance and also increases triglyceride release 
from adipocyte. It is known that glucose toxicity and strong insulin resistance induce inactivation of LPL, which results 
in chylomicronemia.
Conclusion: This case report suggests that when serum triglyceride level is markedly elevated due to diabetic 
lipemia, it is extremely important to obtain good glycemic control.
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Background
Chylomicronemia is caused by several pathologies and 
can be classified as primary and secondary chylomi-
cronemia (Yuan et al. 2007). Making a proper diagnosis 
of the cause of hypertriglycemia is really important as it 
is strongly associated with an increased risk of cardio-
vascular disease and severe pancreatitis. The incidence 
of chylomicronemia reported by the Lipid Research 
Program prevalence study revealed 1.79 per 10,000 indi-
viduals (less than 0.02  %) had triglyceride levels higher 
than 2000  mg/dl (Brunzell et  al. 1982). We present 
herein a case of chylomicronemia accompanied by acute 
exacerbation of type 2 diabetes but dramatically recov-
ered after insulin therapy. Blood color in this subject 
looked like strawberry milk but dramatically changed to 
completely normal transparent after obtaining good gly-
cemic control with insulin therapy.
Case presentation
A 40-year-old male visited our hospital as polydipsia, polyu-
ria and general fatigue developed approximately 2 months 
before. His body weight decreased from 72.7  kg (BMI 
25.5 kg/m2) to 67.6 kg (BMI 23.8 kg/m2) during this term. 
He had been diagnosed with depression and taking mul-
tiple medications and dyslipidemia (T-Chol 263  mg/dl, 
LDL-C 186  mg/dl, HDL-C 48  mg/dl, TG 272  mg/dl) had 
been pointed out in the annual medical check-up conducted 
a year before. The blood drawn for examination presented 
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strawberry milk-like appearance (Fig. 1a, left panel). Labora-
tory test revealed elevated fasting blood glucose and HbA1c; 
306 mg/dl and 12.5 %, respectively. Furthermore, serum tri-
glyceride was markedly elevated up to 5661  mg/dl, which 
presumably caused the dramatic change of blood color. He 
was admitted to our hospital for further examination about 
general fatigue, weight loss and hypertriglycemia. Serum 
amylase and lipase were both within normal range; 64 IU/l 
and 41 U/l, respectively and there were no symptoms which 
suggested pancreatitis. After admission, multiple daily insu-
lin injection was started to obtain good glycemic control. 
The patient was diagnosed with type 2 diabetes as serum 
insulin level (3.4  μU/ml) and urinary C-peptide response 
(>200  µg/day) were preserved and autoantibodies related 
to type 1 diabetes were absent. No diabetic complications 
such as neuropathy, retinopathy and nephropathy were 
observed. Lipemia retinalis was not observed in fundus-
copy. We also conducted further examination to clarify 
the cause of extraordinarily elevated serum triglyceride. 
Chylomicronemia indicated that the patient had type V 
hyperlipoproteinemia. He had no habit of alcohol drink-
ing and hypothyroidism was ruled out from the laboratory 
test (thyroid stimulating hormone (TSH) 1.065  μIU/ml, 
free T3 3.0 pg/ml, free T4 1.1 ng/dl). In addition, no medi-
cations which the patient was taking for depression have 
been reported to exacerbate diabetes or hypertriglycemia. 
We also checked LPL and ApoC-II to rule out any genetic 
factors just in case. As the results, ApoC-II was within nor-
mal range, which excluded ApoC-II deficiency. Serum hep-
arinized lipoprotein lipase (LPL) was within normal range 
(255 ng/mL), which ruled out LDL deficiency, although LPL 
gene mutation screening was not conducted. In addition, 
we checked ApoE genotype to rule out any genetic factors 
just in case. As the results, his ApoE phenotype was E3/E3, 
which is not susceptible to hypertriglycemia compared to 
E2/E2 or E4/E4 (Kei et al. 2015; Shinozaki et al. 2005). Erup-
tive xanthomas were not observed probably because serum 
triglyceride was increased very rapidly together with acute 
exacerbation of type 2 diabetes. The result of treatment 
naive lipoprotein fraction was as shown in Fig.  1b, which 
revealed pre-β-band and prominently elevated VLDL frac-
tion up to 51 %. This patient was taking a large amount of 
soft drinks due to polydipsia before admission, resulting in 
rapid exacerbation of type 2 diabetes and relative insuffi-
ciency of insulin action. Indeed, serum non-esterified fatty 
acid was extremely elevated up to 6.12 mEq/l (normal range 
is 0.14–0.85 mEq/l). We diagnosed this patient as diabetic 
lipemia as there was no finding suggesting genetic hyper-
triglycemia or secondary causes such as multiple myeloma, 
paraproteinemia and systemic lupus erythematosus.
After admission, in order to obtain good glycemic con-
trol, we started multiple daily insulin injection using insu-
lin lispro and glargine. As shown in Fig. 2a, after increasing 
insulin dose, blood glucose level was decreased. Finally, 
when we increased insulin dose up to 40 U (insulin lispro 
30 U, glargine 10 U), good glycemic control was obtained; 
fasting blood glucose levels were approximately 100  mg/
dl. As shown in Fig. 2b, serum triglyceride level was mark-
edly decreased together with the decrease of blood glucose 
level. Serum triglyceride level was as high as 5661 mg/dl 
Lp (a)         8.1
Apo protein (mg/dl)
Apo-A1     105
Apo-A2     24.9
Apo-B       151
Apo-C2     34
Apo-C3     118
Apo-E       24.7

























Fig. 1 a Strawberry milk-like blood before insulin therapy (left panel). Marked change to transparent color after insulin therapy (right panel). Some 
parts of the pictures are obstructed to block personal information. b Treatment naive lipoprotein fraction
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on admission, but its level 1, 4, 6, 8, 13 days after admission 
was 4261, 2196, 1287, 714, 311 mg/dl, respectively. Finally, 
on 14th day, when he was discharged, it was improved to 
272 mg/dl and blood appearance became completely nor-
mal without using any hypolipidemic agents. As shown 
in Fig.  1a (right panel), after insulin therapy, the serum 
became transparent, and there was marked difference 
between before and after insulin therapy, indicating that 
this case was truly diabetic lipemia.
Conclusion and discussion
Chylomicronemia is present when serum triglyceride 
exceeds 1000 mg/dl. Serum triglyceride levels increase as 
insulin resistance reduces triglyceride clearance and also 
increases triglyceride release from adipocyte (Brunzell 
et al. 1982). In this report, extremely elevated non-ester-
ified fatty acid strongly suggests the existence of strong 
insulin resistance and increased triglyceride release from 
adipose tissue. Chylomicrone is mainly metabolized by 
LPL, which is activated by insulin signaling. It is known 
that glucose toxicity and strong insulin resistance induce 
inactivation of LPL, which results in chylomicronemia 
(Sparks et al. 2012). Exacerbation of insulin resistance in 
this case might have been partially attributed to promi-
nent fatty liver in addition to glucose toxicity. As the 
incidence of overweight, obesity and type 2 diabetes is 
increasing drastically worldwide, it is very likely that chy-
lomicronemia and chylomicronemia syndrome, which 
is accompanied by at least one of eruptive xanthoma, 
lipemia retinalis or abdominal findings such as abdomi-
nal pain, acute pancreatitis or hepatosplenomegaly, 
would become more prevalent in the near future. In this 
case, prominent chylomicronemia syndrome was not 
observed. However, we cannot completely exclude the 
possibility that we missed lipemia retinalis as funduscopy 
was carried out after starting insulin treatment.
It is known that the development of chylomicronemia 
is influenced by various genetic factors as well as the 
alteration of dietary life such as overeating. Indeed, his 
mother had dyslipidemia in her fifties, although its details 
were unknown. Therefore, we cannot deny the possibility 
that some genetic factors in addition to the acute exac-
erbation of type 2 diabetes mellitus are involved in the 
development of chylomicronemia in this subject.
In this case, serum TG level was markedly increased up 
to 5661 mg/dl and strawberry milk-like blood color was 
dramatically changed to normal transparent color after 
obtaining good glycemic control with insulin therapy. We 
think that, in everyday clinical practice, it is not so com-
mon to see subjects with type 2 diabetes accompanied by 
such marked increase of TG level and dramatic change 
of blood color. Therefore, we think that this report would 
call for attention from the clinical point of view. In addi-
tion, this case report strongly suggest that when serum 
triglyceride level is markedly elevated due to diabetic 
lipemia, it is very important to obtain good glycemic con-
trol in subjects with type 2 diabetes.
Although diabetes mellitus is the most common sec-
ondary cause of chylomicronemia, when it is observed, 
we need to seek various causes by screening lipoprotein 
fraction and LPL activity. Recently developed novel tech-























































Fig. 2 Alteration of fasting blood glucose level (a) and serum triglyceride level (b) after intensive insulin therapy
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to diagnose genetic hypertriglycemia when the treatment 
is not successful (Hegele et al. 2015).
Taken together, we should be aware of the possibility 
that chylomicronemia could be induced by acute exacer-
bation of glycemic control. In addition, we should keep 
in mind that when serum triglyceride level is markedly 
elevated due to diabetic lipemia, it is very important to 
obtain good glycemic control.
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